Lawrence Otto Klein, Chief Executive Officer at Oruka Therapeutics, sold ORKA on Sep 1, 2026
Data as of Oct 16
▼ SELL$600K6,604 shares at $90.79Lawrence Otto Klein Chief Executive OfficerORKA Oruka Therapeutics, Inc.
- Traded
- Sep 1, 2026
- Disclosed
- Sep 1, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ORKA since disclosure
−21.9%
after the sale
Similar stocks (XLV) since disclosure
+2.9%
XLV — its sector index fund
Change in closing price from Sep 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLLawrence Otto Klein Chief Executive OfficerORKA Oruka Therapeutics, Inc.$444Kdisclosed Sep 1 · filed the same day
- ▼ SELLLawrence Otto Klein Chief Executive OfficerORKA Oruka Therapeutics, Inc.$5.8Mdisclosed Sep 1 · filed the same day